Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ARX vs BWIN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ARX Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 5–5 Matrix Metrics)

ARX Overall Winner 6-Pillar Tally: ARX 4 – 2 BWIN Matrix Metrics: ARX 5 – 5 BWIN

As of Nov 16, 2026, Accelerant Holdings (ARX) is the stronger overall head-to-head candidate over The Baldwin Insurance Group, Inc. (BWIN) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). ARX carries a Unified Composite Score of 46.9/100 (HOLD) at $19.87 (21.3x Forward P/E, 3.7% operating margin), whereas BWIN carries 53.9/100 (HOLD) at $32.14 (13.0x Forward P/E, 1.7% operating margin).

  • Composite vs. Pillar Nuance: While BWIN currently prints a higher short-term Unified Composite Score (53.9/100 HOLD vs. ARX 46.9/100 HOLD), ARX captures the overall institutional head-to-head verdict (5–5 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (3.7% vs. 1.7% operating margin) and revenue trajectory (+6.1% vs. +31.4% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ARX vs BWIN
ARX NYSE Head-to-Head Winner
Accelerant Holdings
Insurance Agents, Brokers & Service
$19.87
+0.1% 1D
Market Cap $4.3B
TTM Revenue $2.79B
Forward P/E 21.3x
Beta / 30D Vol -0.19β · 2% Vol
Unified Composite Score
46.9 / 100 HOLD
Tech 34.0 Fund 50.0 Flow 76.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.5% over 20 days), RSI 70
RSI-14: 69.8 · SMA20: $19.83 · SMA50: $19.80
BWIN NASDAQ
The Baldwin Insurance Group, Inc. Class A Common Stock
Insurance Agents, Brokers & Service
$32.14
+0.28% 1D
Market Cap $4.5B
TTM Revenue $1.85B
Forward P/E 13.0x
Beta / 30D Vol -0.15β · 4% Vol
Unified Composite Score
53.9 / 100 HOLD
Tech 42.0 Fund 47.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.6% over 20 days), RSI 60
RSI-14: 59.6 · SMA20: $31.99 · SMA50: $31.72

6-Pillar Scorecard Institutional Category Breakdown (ARX 4 – 2 BWIN)

Columns: Metric · ARX · BWIN
1. Valuation Multiples BWIN
Forward P/E 21.3x 13.0x
Trailing P/E 27.6x 12.3x
PEG Ratio N/M N/M
EV / Revenue N/M 2.4x
2. Growth & Scale BWIN
Revenue Growth (YoY) +6.1% +31.4%
Earnings Growth (YoY) +800.0% -90.0%
TTM Revenue (USD) $2.79B $1.85B
Market Cap $4.3B $4.5B
3. Profitability & Quality ARX
Gross Margin 62.8% 32.2%
Operating Margin 3.7% 1.7%
Net Profit Margin 5.6% -6.5%
Return on Equity (ROE) 9.2% -14.8%
4. Balance Sheet & Cash Flow ARX
Cash Generation (TTM) $634M $246M EBITDA
Cash Flow Margin 22.7% 13.3% EBITDA Mgn
Net Cash / Leverage $5.13B Net Cash $8.75 Book/Sh · -14.8% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ARX
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 15.7% (3rd %ile) 42.9% (<1st %ile)
Put/Call OI Skew 0.01x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markup
6. R&D & Supply-Chain Moat ARX
OpEx & R&D Intensity 59.1% of Rev ($1.65B) 30.5% of Rev ($565M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance Brokers Operator Insurance Brokers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ARX (5) vs BWIN (5)
Institutional Metric ARX BWIN Criterion Row Edge
Market Capitalization
Scale
$4.3B $4.5B Larger Scale BWIN
Trailing P/E Ratio
Valuation
27.6x 12.3x Lower Multiple BWIN
Forward P/E Ratio
Valuation
21.3x 13.0x Lower Multiple BWIN
Revenue Growth (YoY)
Growth
+6.1% +31.4% Higher Growth BWIN
Operating Margin (TTM)
Profitability
3.7% 1.7% Higher Margin ARX
Net Profit Margin
Profitability
5.6% -6.5% Higher Margin ARX
Return on Equity (ROE)
Capital Efficiency
9.2% -14.8% Higher ROE ARX
52-Week Range Position
Momentum
100% ($9–$20) 97% ($16–$33) Stronger Trend ARX
Beta / 30D Volatility
Risk Regime
-0.19β · 2% Vol -0.15β · 4% Vol Lower Realized Risk ARX
Unified Institutional Score
Composite Signal
46.9 / 100 (HOLD) 53.9 / 100 (HOLD) Higher Composite BWIN
Trailing 12M Revenue (USD)
Operating Scale
$2.79B $1.85B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
62.8% 32.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 2.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$634M ($5.13B Net Cash) $246M EBITDA ($8.75 Book/Sh · -14.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BWIN +0.11 pp
ARX: +0.61% · BWIN: +0.72%
3M Horizon BWIN +4.84 pp
ARX: +1.58% · BWIN: +6.42%
6M Horizon BWIN +29.04 pp
ARX: +24.89% · BWIN: +53.93%
1Y Horizon ARX +28.79 pp
ARX: +44.4% · BWIN: +15.61%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARX vs BWIN. Trailing 12-month operating profitability (ARX 3.7% vs BWIN 1.7%) and valuation multiples (ARX 21.3x vs BWIN 13.0x Forward P/E) are benchmarked directly in Pillar 4 below.

ARX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.79B
Gross Margin62.8%
Op. Margin3.7%
ROE / Fwd P/E9.2% · 21.3x
BWIN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.85B
Gross Margin32.2%
Op. Margin1.7%
ROE / Fwd P/E-14.8% · 13.0x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ARX CONSOLIDATION
50d in phase · OBV NEUTRAL
Current IV 15.7%
IV Percentile 3rd %ile
Put/Call OI Skew 0.01x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ARX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BWIN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 42.9%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BWIN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ARX Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $4.3B market capitalization and 3.7% operating margin.
OpEx & R&D Reinvestment 59.1% of Rev ($1.65B)
90D Engineering Disclosures 0 Published
BWIN Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $4.5B market capitalization and 1.7% operating margin.
OpEx & R&D Reinvestment 30.5% of Rev ($565M)
90D Engineering Disclosures 0 Published

Investor FAQ ARX vs BWIN Key Questions & Quantitative Answers

As of Nov 16, 2026, Accelerant Holdings (ARX) is the stronger overall head-to-head candidate over The Baldwin Insurance Group, Inc. (BWIN) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). ARX carries a Unified Composite Score of 46.9/100 (HOLD) at $19.87 (21.3x Forward P/E, 3.7% operating margin), whereas BWIN carries 53.9/100 (HOLD) at $32.14 (13.0x Forward P/E, 1.7% operating margin). Composite vs. Pillar Nuance: While BWIN currently prints a higher short-term Unified Composite Score (53.9/100 HOLD vs. ARX 46.9/100 HOLD), ARX captures the overall institutional head-to-head verdict (5–5 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (3.7% vs. 1.7% operating margin) and revenue trajectory (+6.1% vs. +31.4% YoY).

BWIN leads the Growth & Scale pillar: ARX posts +6.1% YoY revenue growth and +800.0% YoY earnings growth on $2.79B TTM revenue (62.8% gross margin, 3.7% operating margin), compared with BWIN at +31.4% YoY revenue growth and -90.0% YoY earnings growth on $1.85B TTM revenue (32.2% gross margin, 1.7% operating margin). On trailing 12-month operating scale, ARX generates $2.79B in USD-normalized revenue versus $1.85B for BWIN. In operating R&D and SG&A reinvestment, ARX deploys 59.1% of Rev ($1.65B) (0 90-day corporate R&D disclosures) versus 30.5% of Rev ($565M) (0 disclosures) for BWIN.

BWIN screens cheaper on headline valuation multiples. ARX trades at 21.3x Forward P/E, 27.6x Trailing P/E, N/M PEG, and N/M EV/Revenue (22.7% FCF margin), whereas BWIN trades at 13.0x Forward P/E, 12.3x Trailing P/E, N/M PEG, and 2.4x EV/Revenue (13.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ARX (9.2% ROE) versus BWIN (-14.8% ROE) capital efficiency.

In options market volatility and institutional positioning, ARX carries 15.7% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.19β · 2% Vol realized risk). By comparison, BWIN carries 42.9% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.15β · 4% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.